We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.01B
1-Year Est. Return 47.79%
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+47.79%
3 Year Est. Return
+184.24%
5 Year Est. Return
+273.21%
10 Year Est. Return
+1,255.9%
AUM
$1.68B
AUM Growth
-$28.5M
Cap. Flow
-$141M
Cap. Flow %
-8.41%
Top 10 Hldgs %
15.57%
Holding
173
New
19
Increased
39
Reduced
98
Closed
12

Top Buys

Rank Stock Value
1
HES
Hess
HES
+$18.3M
2
VRNT
Verint Systems
VRNT
+$14.6M
3
CVS icon
CVS Health
CVS
+$8.22M
4
HPQ icon
HP
HPQ
+$7.7M
5
BSX icon
Boston Scientific
BSX
+$6.02M

Top Sells

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$33.9M
2
NBL
Noble Energy, Inc.
NBL
+$22.3M
3
PVH icon
PVH
PVH
+$13M
4
SPLK
Splunk Inc
SPLK
+$12.2M
5
C icon
Citigroup
C
+$9.4M

Sector Composition

Rank Sector Weight
1 Financials 15.71%
2 Technology 15.25%
3 Healthcare 15.02%
4 Industrials 10.76%
5 Energy 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELV icon
26
Elevance Health
ELV
$81.6B
$19.2M 1.14%
178,220
-6,055
-3% -$624K
WFC icon
27
Wells Fargo
WFC
$258B
$19.1M 1.14%
364,238
-28,050
-7% -$1.41M
HD icon
28
Home Depot
HD
$332B
$18.9M 1.12%
233,417
-19,104
-8% -$1.51M
BA icon
29
Boeing
BA
$175B
$18.8M 1.12%
147,942
-11,330
-7% -$1.48M
APH icon
30
Amphenol
APH
$197B
$18.7M 1.11%
1,553,608
-100,936
-6% -$1.2M
MON
31
DELISTED
Monsanto Co
MON
$18.7M 1.11%
149,745
-14,450
-9% -$1.69M
INVN
32
DELISTED
Invensense Inc
INVN
$18.6M 1.11%
821,440
-85,585
-9% -$1.75M
PFE icon
33
Pfizer
PFE
$142B
$18.5M 1.1%
658,331
-12,906
-2% -$368K
AZPN
34
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$18.5M 1.1%
399,095
-43,668
-10% -$2.03M
MA icon
35
Mastercard
MA
$510B
$18.4M 1.09%
249,930
-42,095
-14% -$3.13M
CSX icon
36
CSX Corp
CSX
$93B
$17.9M 1.06%
1,738,287
-26,913
-2% -$262K
ICLR icon
37
Icon
ICLR
$12.8B
$17.8M 1.06%
378,615
-36,790
-9% -$1.59M
MWV
38
DELISTED
MEADWESTVACO CORP
MWV
$17.8M 1.06%
402,851
-13,835
-3% -$561K
COP icon
39
ConocoPhillips
COP
$145B
$17.8M 1.06%
207,470
-2,185
-1% -$170K
MET icon
40
MetLife
MET
$62.5B
$17.7M 1.05%
357,704
-21,026
-6% -$984K
JAH
41
DELISTED
JARDEN CORPORATION
JAH
$17.7M 1.05%
446,607
-98,615
-18% -$3.76M
QCOM icon
42
Qualcomm
QCOM
$159B
$17.4M 1.04%
219,935
-12,160
-5% -$967K
SBNY
43
DELISTED
Signature Bank
SBNY
$17.3M 1.03%
137,138
-7,775
-5% -$935K
CBRE icon
44
CBRE Group
CBRE
$43.3B
$17.1M 1.01%
532,205
-27,805
-5% -$803K
KMB icon
45
Kimberly-Clark
KMB
$36.6B
$16.9M 1.01%
158,581
+525
+0.3% +$55.8K
USB icon
46
US Bancorp
USB
$98B
$16.9M 1.01%
390,027
-28,995
-7% -$1.21M
DHR icon
47
Danaher
DHR
$138B
$16.8M 1%
316,712
-29,172
-8% -$1.5M
BEN icon
48
Franklin Resources
BEN
$17.2B
$16.7M 0.99%
288,910
-42,475
-13% -$2.32M
AMT icon
49
American Tower
AMT
$81.3B
$16.6M 0.98%
184,003
-6,300
-3% -$545K
FISV
50
Fiserv Inc
FISV
$28.8B
$16.5M 0.98%
547,890
-47,700
-8% -$1.41M

Similar funds

Braun Stacey Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Braun Stacey Associates held 173 positions worth $1.68B, down 1.7% from $1.71B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Braun Stacey Associates withdrew a net $141M in Q2 2014, closing 12 positions and reducing 98 holdings. Its most notable exit was Noble Energy, Inc., an estimated $22.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Braun Stacey Associates opened a new position in Hess worth $20M.

  • Braun Stacey Associates's largest Q2 2014 buy was Hess: 202,475 shares worth $20M.
  • Braun Stacey Associates added most to CVS Health in Q2 2014, an estimated $8.22M increase.
  • Braun Stacey Associates's biggest Q2 2014 reduction was EOG Resources, cutting an estimated $33.9M.
  • Braun Stacey Associates fully exited Noble Energy, Inc. in Q2 2014, selling an estimated $22.3M.
  • Braun Stacey Associates's ten largest holdings make up 16% of its $1.68B portfolio in Q2 2014.
  • Braun Stacey Associates opened 19 new positions and closed 12 in Q2 2014.
  • Braun Stacey Associates's portfolio value fell 1.7% quarter-over-quarter to $1.68B.

Based on Braun Stacey Associates's 13F filing for Q2 2014, filed 7 Aug 2014.